T. Rowe Price Associates’s GeneDx Holdings Warrant WGSWW Stock Holding History

T. Rowe Price Associates’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Hold	243,780	–	–	﹤0.01%	3130
2025 Q4	$10K	Hold	243,780	–	–	﹤0.01%	3085
2025 Q3	$25K	Hold	243,780	–	–	﹤0.01%	3034
2025 Q2	$15K	Hold	243,780	–	–	﹤0.01%	3051
2025 Q1	$52K	Sell	243,780 -7,150	-3%	-$1.6K	﹤0.01%	2924
2024 Q4	$41K	Hold	250,930	–	–	﹤0.01%	2961
2024 Q3	$19K	Hold	250,930	–	–	﹤0.01%	2992
2024 Q2	$6K	Hold	250,930	–	–	﹤0.01%	2911
2024 Q1	$14K	Hold	250,930	–	–	﹤0.01%	2938
2023 Q4	$3K	Hold	250,930	–	–	﹤0.01%	2902
2023 Q3	$8K	Sell	250,930 -9,622	-4%	-$267	﹤0.01%	2873
2023 Q2	$2K	Sell	260,552 -4,874	-2%	-$86	﹤0.01%	2886
2023 Q1	$5K	Sell	265,426 -14,768	-5%	-$351	﹤0.01%	2901
2022 Q4	$5K	Sell	280,194 -15,849	-5%	-$1.64K	﹤0.01%	2914
2022 Q3	$66K	Sell	296,043 -1,241	-0.4%	-$348	﹤0.01%	2795
2022 Q2	$97K	Sell	297,284 -1	-0%	–	﹤0.01%	2760
2022 Q1	$205K	Sell	297,285 -399,709	-57%	-$276K	﹤0.01%	2703
2021 Q4	$683K	Hold	696,994	–	–	﹤0.01%	2231
2021 Q3	$1.48M	Buy	+696,994	New	+$2.29M	﹤0.01%	1859

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $879M AUM 29.99% 1-Year Est. Return

T. Rowe Price Associates's WGSWW Position: Q1 2026 in Review

T. Rowe Price Associates held its GeneDx Holdings Warrant (WGSWW) position steady in Q1 2026 at 243,780 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

T. Rowe Price Associates first reported a position in WGSWW in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q3 2021. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

T. Rowe Price Associates held 243,780 shares of GeneDx Holdings Warrant worth $2K as of Q1 2026.
T. Rowe Price Associates left its GeneDx Holdings Warrant share count unchanged in Q1 2026.
GeneDx Holdings Warrant made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3130 holding.
T. Rowe Price Associates first reported a position in GeneDx Holdings Warrant in Q3 2021 and has held it in 19 quarters since.
T. Rowe Price Associates's GeneDx Holdings Warrant position peaked at $1.48M in Q3 2021.
13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.